Our mission is very straightforward: eliminate the burden of cancer. Our team of more than 160 world-class researchers and clinicians are raising cancer research, drug development and delivery, prevention and survivorship, and patient care to a higher standard, with one goal in mind: defeating cancer.
Nanotax: The University of Kansas Cancer Center is currently enrolling patients in this Phase I Clinical Trial.
Click here to learn more.
Led by Scott Weir, PharmD, PhD, the Institute recently launched and focuses on the discovery and commercialization of medical innovations, and training the next generation of translational scientists. Proof of Concept funding is available through the Institute, and request for proposals are currently open. Click here to access the RFP and application that is due June 12th.
Purchase Your Driven to Cure License Plate Today
©
The University of Kansas Medical Center
